Drug Ad Crackdown Demonstrates Admin's Aggressive Stance

On Sept. 9, the U.S. Food and Drug Administration issued a press release announcing "sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements,"[1] while simultaneously sending a templated letter[2] to thousands...

Already a subscriber? Click here to view full article